Growth Metrics

Immunome (IMNM) Operating Margin (2023 - 2025)

Immunome posted quarterly Operating Margin of 1157.61% for Q2 2025, up 53482.0% year-on-year from N/an in Q2 2024, and up 24.12% on a QoQ basis from 1525.5% in Q1 2025.

Immunome (IMNM) has 3 years of Operating Margin data on file, last reported at 1157.61% in Q2 2025.

  • For the quarter ending Q2 2025, Operating Margin rose 53482.0% year-over-year to 1157.61%; the trailing twelve-month figure through Mar 2026 stood at 5947.9% (down 395359.0% YoY), and the FY2025 full-year result was 3228.83%, up 15354.0% from the prior year.
  • Operating Margin for Q2 2025 stood at 1157.61%, up from 1525.5% in the prior quarter.
  • Across five years, Operating Margin topped out at 129.96% in Q3 2023 and bottomed at 12857.05% in Q1 2024.
  • The 3-year median for Operating Margin is 1608.96% (2025), against an average of 2492.75%.
  • The widest annual swing landed in 2024, when Operating Margin slumped 1266792 bps; it then surged 1133155 bps in 2025.
  • A 3-year view of Operating Margin shows it stood at 2473.94% in 2023, then slipped by 22 bps to 3030.31% in 2024, then jumped by 62 bps to 1157.61% in 2025.
  • The last three Operating Margin figures came in at 1157.61% (Q2 2025), 1525.5% (Q1 2025), and 3030.31% (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -6.43%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 38.10%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 17.83%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 23.02%
10 Immunome 2.47 Bn 1.89 Bn - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2025 -1,157.61%
Mar 31, 2025 -1,525.50%
Dec 31, 2024 -3,030.31%
Sep 30, 2024 -1,736.15%
Jun 30, 2024 -1,692.43%
Mar 31, 2024 -12,857.05%
Dec 31, 2023 -2,473.94%
Sep 30, 2023 -129.96%
Jun 30, 2023 -135.42%
Mar 31, 2023 -189.13%